Warner Chilcott Buyout Values Women’s Health Rx Firm At $3 Bil.

Buyout by DLJ and J.P. Morgan investment groups will complete transformation of U.K. company into U.S.-focused specialty women’s health firm. Investor group plans to retain current Warner Chilcott management following sale.